GSK plc (GSK)
LSE
Real-time Data
07:00 AM
Day's Range
1,875.5052 wk Range
17.23Profile - GSK - GSK plc
Profile
Mic Code
XLON
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
66.84K
GSK plc is a global biopharma company dedicated to uniting science, technology, and talent to get ahead of disease. Its primary purpose is to positively impact the health of 2.5 billion people by the end of the decade through innovative prevention and treatment strategies. The company focuses its research and development efforts on four key therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases, leveraging advanced tools like digital biological twins and organoids to accelerate drug discovery. GSK plc emphasizes long-acting therapies for HIV, novel treatments for asthma and nasal polyps, and efforts to make cancer curable, while addressing global health challenges such as high-burden infectious diseases in lower-income countries. Committed to responsibility, it pursues net zero emissions, nature-positive goals, affordable access programs, and inclusive research to meet diverse patient needs. With a significant U.S. presence employing around 15,000 people across commercial, R&D, manufacturing, and corporate functions, GSK plc plays a pivotal role in advancing biopharmaceutical innovation and health security worldwide.
Profile Details
Type
Common Stock
Ceo
Mr. Luke Victor Miels
Address
79 New Oxford Street
City
London
Zip
WC1A 1DG
Country
United Kingdom
Phone
44 20 8047 5000
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
